— george (@probiotic_man) September 7, 2018
In this recent study they concluded:
Colonic biofermentative function is markedly impaired in MS patients.The ketogenic diet normalized concentrations of the colonic microbiome after 6 months.
This direction is worthy of more study.
More research into the microbiome as a vector of treatment is being undertaken by mainstream medicine. The treatment of Clostridium difficile (C. difficile) infections was the more recent area of focus but now other areas are being considered.
This excellent research paper not only comments on the use of fecal microbiota transplants for metabolic syndrome, but it also provides a concise history fecal transplantation.
Fecal microbiota transplantation in metabolic syndrome: History, present and future: Full Article
As mentioned earlier, the most widely accepted explanation for the origin of metabolic syndrome is translocation of endotoxin (LPS) or direct translocation of gram-negative microbes, causing low grade inflammation. However, data on this phenomenon are still inconclusive.
Do see our forum thread about metabolic syndrome for more information on the subject.
— Thorsten Hagemann (@HealthyBiome) March 10, 2017
From the discussion of the study mentioned in the above article:
Our meta-analysis suggests consuming probiotics appears to be beneficial by decreasing some inflammatory cytokines and biomarkers that may play a role in the development of cardiovascular disease and type 2 diabetes mellitus.